AzTrials
AzTrials

CraniosynostosisAmAcNCT02287805

Qualitative and Quantitative Study Which Aims to Determine the Specifics of the Announcement for the Diagnosis of Patients With Craniosynostosis and Their Parents to Better Support Them in Their Care

An observational study of Craniosynostosis, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purposes of this study are: to better understand the experience of the announcement for the diagnostic of craniosynostosis to patients and their families to improve the understanding of it and it modes of appropriation to compare the announcement process concerning "simple" and "complex" forms. Read more about this study

Who is it for?
Any age
Conditions the study is for
Craniosynostosis
What is being tested?
qualitative survey and quantitative survey
How many people
574 participants
Where
1 siteFrance
Study dates
Oct 2014to Jul 2016
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: children with craniosynostosis who are followed by the Reference Center "Dysostoses craniofaciales" and their parents.

Who may be able to join

  • Group 1 :
  • Parents of operated children with a clinical diagnosis of craniosynostosis
  • Group 2 :
  • Parents of newly diagnosed children for a craniosynostosis who will be operated
  • Children aged 15 who were operated for a craniosynostosis at least 10 years ago
  • Group 3 :
  • Parents of newly diagnosed children for a craniosynostosis who will be operated
  • Children aged 15 who were operated for a craniosynostosis at least 10 years ago

Who cannot join

  • nothing to declare

Trial locations and contacts

1 site in 1 country.

France1 site
  • Centre de référence des dysostoses craniofaciales, Hôpital Necker Enfants Malades

    Paris, 75015

Other trials in France

About this study

Official title: Craniosynostosis: How to Improve the Diagnosis and Assist Patients and Their Families?

The purposes of this study are:

  • to better understand the experience of the announcement for the diagnostic of craniosynostosis to patients and their families to improve the understanding of it and it modes of appropriation
  • to compare the announcement process concerning "simple" and "complex" forms.
  • to identify the intra-family issues at the announcement of a genetic mutation.
  • to reconstruct the care course of patients by analyzing the time of the announcement and the post-operative period.
Read the detailed description

The supported hypothesis is that the diagnosis of craniosynostosis disturbs the initial family pattern. The different forms of the disease will have different repercussions on intra-family relationships.

The quality of the announcement done by the doctor influences the way how the subjects (parents and patients themselves) appropriate and incorporate it at short, medium and long term.

This research will contribute to the knowledge of this rare disease by different scientific communities: social sciences, medicine and neuropsychology. The originality of this research lies in interdisciplinary teams involved and the cross looks between professional and associative fields.

To better understand the impact of congenital malformations and specifically those related to craniosynostosis, the experiences of children and their families at short, medium and long term, the research will take place in the center of reference "Dysostoses craniofacial", Pediatric Neurosurgery Service at the Necker Hospital in Paris.

Prior to fieldwork, a thorough literature search will be conducted on issues related to our subject: the announcement, psychological, identity, family and social impacts, as well as the specifics of the disease and its manifestations.

The fieldwork will be included in a longitudinal approach which will be located at the intersection of quantitative and qualitative methods.

Being tested
qualitative survey, quantitative survey
Keywords
craniosynostosis, simple form, complex form, diagnostic, announcement, impacts
Medical subject headings
Craniosynostoses, Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • qualitative surveyOther

  • quantitative surveyOther

Study groups in NCT02287805
Study groupRoleWhat they receive
quantitative survey 1parents of 300 patients with craniosynostosis diagnostic
Receives: Other: quantitative survey
qualitative survey* parents of 12 newly diagnosed patients, they will be seen 3 times (after the diagnosis, 3 months after surgery, 1 year after surgery * 12 patients aged over 15 years, operated more than 10 years before
Receives: Other: qualitative survey
quantitative survey 2* 100 parents of patients 1 year after surgery * 100 parents of patients, 5 years after the operation * 100 patients aged over 15 years and operated over 10 years ago
Receives: Other: quantitative survey

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. measure by questionnaire the conditions and experiences of the announcement concerning craniosynostosis (simple or complex)

    Analysis of the questionnaires will permit us to learn more about the conditions and experiences of the announcement concerning different profiles families whose experience has been received differently depending on the type of craniosynostosis (simple or complex), the medical history or sociodemographic characteristics.

    Measured: 5 months

Secondary outcomes (2)
  1. measure by interview the conditions and experiences of the announcement concerning craniosynostosis (simple or complex) interview

    In a longitudinal perspective, we will develop interview guides. For conducting interviews, we will use the life story method. The interest of the life story is that it provides a method to study the modes of appropriation of the announcement and the way in which subjects incorporate it into their life history.

    Measured: 16 months

  2. measure by an other questionnaire the conditions and experiences of the announcement concerning craniosynostosis (simple or complex)

    From the results of all the interviews (from qualitative survey) and the analysis of questionnaires from the quantitative survey 1, we will develop questionnaires for themes and issues that have emerged from those analyses (accompanying the announcement of genetic mutation in the family, aesthetics, education ...). It will then develop targeted questionnaires, based on the analysis of interviews and questionnaires from the quantitative survey. The goal will be a deepening of themes.

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Nov 2014 (estimated)
  2. Study startOct 2014
  3. Primary completionJan 2016
  4. Study completionJul 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
574 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02287805
Sponsor's protocol ID
URC 1073
Acronym
AmAc
Status last verified
Mar 2026
First submitted
10 Oct 2014
Last updated
6 Apr 2026
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Craniosynostosis, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

measure by questionnaire the conditions and experiences of the announcement concerning craniosynostosis (simple or complex) (time frame: 5 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Apr 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in